Sign inJoin waitlistJoin the waitlist

Swati Naik

Pediatrics / Pediatric Hematology-Oncology

Credentials: · · · ·

History

Pediatrics
2009–2012
Deccan College of Medical Sciences, Hyderabad, India
2005–2009

Research

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell…
Journal of Clinical Oncology · 2017 · 386 citations
T cells redirected to EphA2 for the immunotherapy of glioblastoma
Molecular Therapy · 2013 · 215 citations
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
Blood · 2015 · 187 citations

Stephen Gottschalk
34 papers
Aimee Talleur
21 papers
Brandon Triplett
20 papers
Helen Heslop
17 papers
Caridad Martinez
16 papers
Rebecca Epperly
15 papers · 2 as a fellow
GS
Ghadir Sasa
12 papers
Akshay Sharma
11 papers
Bilal Omer
11 papers
Malcolm Brenner
11 papers
KL
Kathryn Leung
8 papers
Amr Qudeimat
7 papers

Grants

CD45RA-DEPLETED CD19-CAR T CELL CONSOLIDATION AFTER TCR Alphabeta+ T CELL-DEPLETED HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY CD19+ ALL AND LYMPHOMA
National Cancer Institute · R01
Contact PI · $737K · St. Jude Children's Research Hospital
2026–2031

Clinical trials

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Principal investigator · Recruiting · Phase 1
St. Jude Children's Research Hospital
2026–2035
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
Principal investigator · Recruiting · Phase 1
St. Jude Children's Research Hospital
2024–2031
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Principal investigator · Recruiting · Phase 1
St. Jude Children's Research Hospital
2020–2030
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Principal investigator · Withdrawn · Phase 1
AlloVir
2018–2019